Remission without Admission

In 2014, Ralph Hills was diagnosed with acute myeloid leukemia (AML) and his doctors told him to “get your affairs in order." Everything changed when he enrolled in an innovative clinical trial. Learn about the treatment that put his cancer into remission without requiring him to be admitted to the hospital.

There's an App for That

Last year, Apple unveiled a new platform that offers a streamlined way to create mobile applications linked to medical research. The technology, called ResearchKit, lets investigators more easily connect with the people whose diseases they're studying, allowing them to gather feedback on symptoms, as well as data on everything from a patient's weight to the air quality where they live.

Researchers Develop Method to Identify Patient-Specific Drugs for Treating Diabetes

An innovative method that uses human embryonic stem cells to model type 2 diabetes caused by genetic mutations may enable researchers to identify drugs that could treat the disease. The research by Weill Cornell Medicine investigators was published Aug. 11 in Cell Stem Cell, and may extend the use of precision medicine to metabolic diseases.

We Are Weill Cornell Medicine: Dr. Olivier Elemento

Computational biologist Dr. Olivier Elemento was just 6 years old when he received his first microscope and computer. Now he is harnessing the power of both to spot patterns and trends in cancer that could help doctors treat the disease — and perhaps even find a cure.

Tall Order

AN AMBITIOUS STUDY AIMS TO UNDERSTAND HOW CROHN'S DISEASE STUNTS KIDS' GROWTH

Eventually, Alex's parents brought him to NewYork-Presbyterian/Weill Cornell Medical Center, where he saw Dr. Thomas Ciecierega, an assistant professor of pediatrics. Dr. Ciecierega made the correct diagnosis — Crohn's disease, a type of inflammatory bowel disease (IBD) that is characterized by intestinal inflammation — and put the boy on the proper course of medication.

New Big Data Approach Predicts Drug Toxicity in Humans

Researchers can now predict the odds of experimental drugs succeeding in clinical trials, thanks to a new data-driven approach developed by Weill Cornell Medicine scientists. The method detects toxic side effects that may disqualify drugs from human use, giving drug developers an early warning before initiating clinical trials, according to a new study published Sept. 15 in Cell Chemical Biology.

Why is a clinical trial so important?

Virtually every advance we have in medicine, virtually everything we do to try to improve outcomes for patients or understand their illnesses comes from clinical trials. So it is really an essential part of moving medicine forward and moving treatments forward to provide better care for patients.

To learn more about clinical trials and the importance of futhering research [go]

Grant Launches Center on the Physics of Cancer Metabolism

The mechanisms controlling how breast cancer develops, spreads to other parts of the body and responds to therapy remain poorly understood, but researchers from the Cornell University College of Engineering and Weill Cornell Medicine hope to change that through the Center on the Physics of Cancer Metabolism — a new multi-institutional translational research unit to be established with a National Cancer Institute grant.

Former Detective Set to Become Investigator of a Different Kind: A Scientist

As an undercover investigator in the New York Police Department's organized crime unit, Christian Saffran had a knack for identifying underlying causes of criminal activity. In a job where being nimble could mean the difference between life and death, he thrived on seeing beyond the obvious to secure arrest warrants and make communities safer.

$1M NIH Grant Helps Researchers Refine Quick Cancer Test

By Blaine Friedlander

One of the most common cancers in sub-Saharan Africa, Kaposi's sarcoma has significant morbidity and mortality rates.